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Coronavirus Disease 2019 (COVID-19)
Interim Additional Guidance for Infection Prevention
and Control Recommendations for Patients with
Suspected or Confirmed COVID-19 in Outpatient
Hemodialysis Facilities
Background
These recommendations should be used with the CDC’s Interim Infection Prevention and Control Recommendations for
Patients with Confirmed Coronavirus Disease 2019 (COVID-19) or Persons Under Investigation for COVID-19 in Healthcare
Settings. This information is provided to clarify COVID-19 infection prevention and control (IPC) recommendations that
are specific to outpatient hemodialysis facilities. This information complements, but does not replace, the general IPC
recommendations for COVID-19.
This guidance is based on the currently available information about COVID-19. This approach will be refined and updated
as more information becomes available and as response needs change in the United States. It is important to stay
informed about COVID-19 to prevent introduction and minimize spread of COVID-19 in your dialysis facility. Consult with
public health authorities to understand if community transmission of COVID-19 is occurring in your community.
Recommendations
A part of routine infection control, outpatient dialysis facilities should have established policies and practices to reduce
the spread of contagious respiratory pathogens. This includes:
Early recognition and isolation of individuals with respiratory infection:
Facilities should implement sick leave policies that are non-punitive, flexible and consistent with public health
policies that allow ill healthcare personnel (HCP) to stay home. HCP should be reminded to not report to work when
they are ill.
Facilities should identify patients with signs and symptoms of respiratory infection (e.g., fever, cough) before they
enter the treatment area.
Instruct patients to call ahead to report fever or respiratory symptoms so the facility can be prepared for their
arrival or triage them to a more appropriate setting (e.g., an acute care hospital).
Patients should inform staff of fever or respiratory symptoms immediately upon arrival at the facility (e.g.,
when they check in at the registration desk).
Patients with symptoms of a respiratory infection should put on a facemask at check-in and keep it on until
they leave the facility.
Facilities should provide patients and HCP with instructions (in appropriate languages) about hand hygiene,
respiratory hygiene, and cough etiquette.
Instructions should include how to use facemasks, how to use tissues to cover nose and mouth when coughing
or sneezing, how to dispose of tissues and contaminated items in waste receptacles, and how and when to
perform hand hygiene.
Post signs at clinic entrances with instructions for patients with fever or symptoms of respiratory infection to
alert staff so appropriate precautions can be implemented.
Facilities should have supplies positioned close to dialysis chairs and nursing stations to ensure adherence to hand
and respiratory hygiene, and cough etiquette. These include tissues and no-touch receptacles for disposal of tissues
and hand hygiene supplies (e.g., alcohol-based hand sanitizer).
Patient placement: Facilities should have space in waiting areas for ill patients to sit separated from other patients
by at least 6 feet. Medically stable patients might opt to wait in a personal vehicle or outside the healthcare facility
where they can be contacted by mobile phone when it is their turn to be seen.
Patients with respiratory symptoms should be brought back to an appropriate treatment area as soon as
possible in order to minimize time in waiting areas.
Facilities should maintain at least 6 feet of separation between masked, symptomatic patients and other
patients during dialysis treatment. Ideally, symptomatic patients would be dialyzed in a separate room (if
available) with the door closed.
Hepatitis B isolation rooms should only be used for dialysis patients with symptoms of respiratory
infection if: 1) the patient is hepatitis B surface antigen positive or 2) the facility has no patients on the
census with hepatitis B infection who would require treatment in the isolation room.
If a separate room is not available, the masked patient should be treated at a corner or end-of-row
station, away from the main flow of traffic (if available). The patient should be separated by at least 6 feet
from the nearest patient (in all directions).
If the patient is unable to tolerate a mask, then they should be separated by at least 6 feet from the
nearest patient station (in all directions).
Personal protective equipment: In general, HCP caring for patients with undiagnosed respiratory infections
should follow Standard, Contact, and Droplet Precautions with eye protection unless the suspected diagnosis
requires Airborne Precautions (e.g., tuberculosis). This includes the use of:
Gloves
Facemask
Eye protection (e.g., goggles, a disposable face shield that covers the front and sides of the face). Personal
glasses and contact lenses are NOT considered adequate eye protection.
Isolation gown
The isolation gown should be worn over or instead of the cover gown (i.e., laboratory coat, gown, or apron
with incorporate sleeves) that is normally worn by hemodialysis personnel. If there are shortages of
gowns, they should be prioritized for initiating and terminating dialysis treatment, manipulating access
needles or catheters, helping the patient into and out of the station, and cleaning and disinfection of
patient care equipment and the dialysis station.
When gowns are removed, place the gown in a dedicated container for waste or linen before leaving the
dialysis station. Disposable gowns should be discarded after use. Cloth gowns should be laundered after
each use.
When COVID-19 is suspected or confirmed in a patient receiving hemodialysis at the facility, the following
additional measures apply:
The health department should be notified about the patient.
HCP should follow the Interim Infection Prevention and Control Recommendations for Patients with Confirmed
Coronavirus Disease 2019 (COVID-19) or Persons Under Investigation for COVID-19 in Healthcare Settings. This
includes recommendations on PPE. Routine cleaning and disinfection are appropriate for COVID-19 in dialysis
settings. Any surface, supplies, or equipment (e.g., dialysis machine) located within 6 feet of symptomatic patients
should be disinfected or discarded.
Products with EPA-approved emerging viral pathogens claims are recommended for use against COVID-19.
Refer to List N  on the EPA website for EPA-registered disinfectants that have qualified under EPA’s
emerging viral pathogens program from use against SARS-CoV-2.
If a hemodialysis facility is dialyzing more than one patient with suspected or confirmed COVID-19,
consideration should be given to cohorting these patients and the HCP caring for them together in the
section of the unit and/or on the same shift (e.g., consider the last shift of the day). If the etiology of
respiratory symptoms is known, patients with different etiologies should not be cohorted (for example,
patients with confirmed influenza and COVID-19 should not be cohorted).
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